Testing effectiveness (Phase 2)Study completedNCT00096239
What this trial is testing
CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Jonsson Comprehensive Cancer Center